Puma Biotechnology Presents Updated Findings From The TBCRC-022 Trial At The 2022 San Antonio Breast Cancer Symposium
Puma Biotechnology Inc PBYI:
PUMA BIOTECHNOLOGY PRESENTS UPDATED FINDINGS FROM THE TBCRC-022 TRIAL AT THE 2022 SAN ANTONIO BREAST CANCER SYMPOSIUM